{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:55:21Z","timestamp":1781654121723,"version":"3.54.5"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":49,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Clinical Research Special Project of Shanghai Municipal Health Commission","award":["Project No. 202540013"],"award-info":[{"award-number":["Project No. 202540013"]}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2506704"],"award-info":[{"award-number":["2023YFC2506704"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2506706"],"award-info":[{"award-number":["2023YFC2506706"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFA1301103"],"award-info":[{"award-number":["2021YFA1301103"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFC2506700"],"award-info":[{"award-number":["2023YFC2506700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023ZD0508401"],"award-info":[{"award-number":["2023ZD0508401"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018630","name":"Shanghai Municipal People's Government","doi-asserted-by":"publisher","award":["22Y31900300"],"award-info":[{"award-number":["22Y31900300"]}],"id":[{"id":"10.13039\/501100018630","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020732","name":"Innovative Research Team of High-level Local University in Shanghai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003399","name":"Science and Technology Commission of Shanghai Municipality","doi-asserted-by":"publisher","award":["Project No. 24DZ2307200"],"award-info":[{"award-number":["Project No. 24DZ2307200"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03194-0","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T04:34:49Z","timestamp":1777437289000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolomic signatures of hepatic steatosis reveal heterogeneity in cardiometabolic risk and responses to lifestyle interventions in type 2 diabetes: a post hoc analysis"],"prefix":"10.1186","volume":"25","author":[{"given":"Xianglin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feixue","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youjin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoran","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieli","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiange","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinli","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5386-4975","authenticated-orcid":false,"given":"Bin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4829-5915","authenticated-orcid":false,"given":"Yufang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6514-2729","authenticated-orcid":false,"given":"Mian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"10","key":"3194_CR1","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","volume":"22","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Golabi P, Price JK, et al. The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with Type 2 diabetes. Clin Gastroenterol Hepatol. 2024;22(10):1999-2010.e8. https:\/\/doi.org\/10.1016\/j.cgh.2024.03.006.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"3194_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.cmet.2019.11.018","volume":"31","author":"A Al-Mrabeh","year":"2020","unstructured":"Al-Mrabeh A, Zhyzhneuskaya SV, Peters C, et al. Hepatic lipoprotein export and remission of human Type 2 diabetes after weight loss. Cell Metab. 2020;31(2):233-249.e4. https:\/\/doi.org\/10.1016\/j.cmet.2019.11.018.","journal-title":"Cell Metab"},{"issue":"4","key":"3194_CR3","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.cmet.2018.07.003","volume":"28","author":"R Taylor","year":"2018","unstructured":"Taylor R, Al-Mrabeh A, Zhyzhneuskaya S, et al. Remission of human Type 2 diabetes requires decrease in liver and pancreas fat content but is dependent upon capacity for \u03b2 cell recovery. Cell Metab. 2018;28(4):547-556.e3. https:\/\/doi.org\/10.1016\/j.cmet.2018.07.003.","journal-title":"Cell Metab"},{"issue":"7","key":"3194_CR4","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2337\/dci24-0094","volume":"48","author":"K Cusi","year":"2025","unstructured":"Cusi K, Abdelmalek MF, Apovian CM, et al. Metabolic dysfunction-associated steatotic liver disease (MASLD) in people with diabetes: the need for screening and early intervention. A consensus report of the American Diabetes Association. Diabetes Care. 2025;48(7):1057\u201382. https:\/\/doi.org\/10.2337\/dci24-0094.","journal-title":"Diabetes Care"},{"issue":"1","key":"3194_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/s2468-1253(23)00270-4","volume":"9","author":"KWM Abeysekera","year":"2024","unstructured":"Abeysekera KWM, Valenti L, Younossi Z, et al. Implementation of a liver health check in people with Type 2 diabetes. Lancet Gastroenterol Hepatol. 2024;9(1):83\u201391. https:\/\/doi.org\/10.1016\/s2468-1253(23)00270-4.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"3194_CR6","doi-asserted-by":"publisher","first-page":"3614","DOI":"10.1038\/s41591-024-03284-0","volume":"30","author":"O Jamialahmadi","year":"2024","unstructured":"Jamialahmadi O, De Vincentis A, Tavaglione F, et al. Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease. Nat Med. 2024;30(12):3614\u201323. https:\/\/doi.org\/10.1038\/s41591-024-03284-0.","journal-title":"Nat Med"},{"issue":"772","key":"3194_CR7","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adh9940","volume":"16","author":"J Ding","year":"2024","unstructured":"Ding J, Liu H, Zhang X, et al. Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population. Sci Transl Med. 2024;16(772):eadh9940. https:\/\/doi.org\/10.1126\/scitranslmed.adh9940.","journal-title":"Sci Transl Med"},{"issue":"8","key":"3194_CR8","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.2337\/dc12-1760","volume":"36","author":"R Lehmann","year":"2013","unstructured":"Lehmann R, Franken H, Dammeier S, et al. Circulating lysophosphatidylcholines are markers of a metabolically benign nonalcoholic fatty liver. Diabetes Care. 2013;36(8):2331\u20138. https:\/\/doi.org\/10.2337\/dc12-1760.","journal-title":"Diabetes Care"},{"key":"3194_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230x-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, et al. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33. https:\/\/doi.org\/10.1186\/1471-230x-6-33.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"3194_CR10","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1053\/j.gastro.2009.06.005","volume":"137","author":"A Kotronen","year":"2009","unstructured":"Kotronen A, Peltonen M, Hakkarainen A, et al. Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors. Gastroenterology. 2009;137(3):865\u201372. https:\/\/doi.org\/10.1053\/j.gastro.2009.06.005.","journal-title":"Gastroenterology"},{"issue":"7","key":"3194_CR11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.dld.2009.08.002","volume":"42","author":"JH Lee","year":"2010","unstructured":"Lee JH, Kim D, Kim HJ, et al. Hepatic steatosis index: a simple screening tool reflecting nonalcoholic fatty liver disease. Dig Liver Dis. 2010;42(7):503\u20138. https:\/\/doi.org\/10.1016\/j.dld.2009.08.002.","journal-title":"Dig Liver Dis"},{"issue":"4","key":"3194_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/apt.14172","volume":"46","author":"TC Yip","year":"2017","unstructured":"Yip TC, Ma AJ, Wong VW, et al. Laboratory parameter-based machine learning model for excluding non-alcoholic fatty liver disease (NAFLD) in the general population. Aliment Pharmacol Ther. 2017;46(4):447\u201356. https:\/\/doi.org\/10.1111\/apt.14172.","journal-title":"Aliment Pharmacol Ther"},{"issue":"11","key":"3194_CR13","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1038\/s41592-021-01303-3","volume":"18","author":"L Chen","year":"2021","unstructured":"Chen L, Lu W, Wang L, et al. Metabolite discovery through global annotation of untargeted metabolomics data. Nat Methods. 2021;18(11):1377\u201385. https:\/\/doi.org\/10.1038\/s41592-021-01303-3.","journal-title":"Nat Methods"},{"issue":"2","key":"3194_CR14","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/hep.29359","volume":"67","author":"P Puri","year":"2018","unstructured":"Puri P, Daita K, Joyce A, et al. The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids. Hepatology. 2018;67(2):534\u201348. https:\/\/doi.org\/10.1002\/hep.29359.","journal-title":"Hepatology"},{"issue":"3","key":"3194_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.metabol.2010.03.006","volume":"60","author":"SC Kalhan","year":"2011","unstructured":"Kalhan SC, Guo L, Edmison J, et al. Plasma metabolomic profile in nonalcoholic fatty liver disease. Metabolism. 2011;60(3):404\u201313. https:\/\/doi.org\/10.1016\/j.metabol.2010.03.006.","journal-title":"Metabolism"},{"issue":"10","key":"3194_CR16","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1007\/s00125-013-2981-2","volume":"56","author":"M Ore\u0161i\u010d","year":"2013","unstructured":"Ore\u0161i\u010d M, Hy\u00f6tyl\u00e4inen T, Kotronen A, et al. Prediction of non-alcoholic fatty-liver disease and liver fat content by serum molecular lipids. Diabetologia. 2013;56(10):2266\u201374. https:\/\/doi.org\/10.1007\/s00125-013-2981-2.","journal-title":"Diabetologia"},{"issue":"7","key":"3194_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-021-01810-6","volume":"17","author":"FN Mazzini","year":"2021","unstructured":"Mazzini FN, Cook F, Gounarides J, et al. Plasma and stool metabolomics to identify microbiota derived-biomarkers of metabolic dysfunction-associated fatty liver disease: effect of PNPLA3 genotype. Metabolomics. 2021;17(7):58. https:\/\/doi.org\/10.1007\/s11306-021-01810-6.","journal-title":"Metabolomics"},{"issue":"11","key":"3194_CR18","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.2337\/dc13-0102","volume":"36","author":"S Haufe","year":"2013","unstructured":"Haufe S, Haas V, Utz W, et al. Long-lasting improvements in liver fat and metabolism despite body weight regain after dietary weight loss. Diabetes Care. 2013;36(11):3786\u201392. https:\/\/doi.org\/10.2337\/dc13-0102.","journal-title":"Diabetes Care"},{"key":"3194_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/nu13030966","author":"CD Crabtree","year":"2021","unstructured":"Crabtree CD, Kackley ML, Buga A, et al. Comparison of ketogenic diets with and without ketone salts versus a low-fat diet: liver fat responses in overweight adults. Nutrients. 2021. https:\/\/doi.org\/10.3390\/nu13030966.","journal-title":"Nutrients"},{"key":"3194_CR20","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5856201","volume":"2018","author":"D Maciejewska","year":"2018","unstructured":"Maciejewska D, Marlicz W, Ryterska K, Banaszczak M, Jamio\u0142-Milc D, Stachowska E. Changes of the fatty acid profile in erythrocyte membranes of patients following 6-month dietary intervention aimed at the regression of nonalcoholic fatty liver disease (NAFLD). Can J Gastroenterol Hepatol. 2018;2018:5856201. https:\/\/doi.org\/10.1155\/2018\/5856201.","journal-title":"Can J Gastroenterol Hepatol"},{"issue":"1","key":"3194_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-10481-9","volume":"12","author":"AF Babu","year":"2022","unstructured":"Babu AF, Csader S, M\u00e4nnist\u00f6 V, et al. Effects of exercise on NAFLD using non-targeted metabolomics in adipose tissue, plasma, urine, and stool. Sci Rep. 2022;12(1):6485. https:\/\/doi.org\/10.1038\/s41598-022-10481-9.","journal-title":"Sci Rep"},{"issue":"6","key":"3194_CR22","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.2337\/dc24-0241","volume":"47","author":"M Li","year":"2024","unstructured":"Li M, Li J, Xu Y, et al. Effect of 5:2 regimens: energy-restricted diet or low-volume high-intensity interval training combined with resistance exercise on glycemic control and cardiometabolic health in adults with overweight\/obesity and type 2 diabetes: a three-arm randomized controlled trial. Diabetes Care. 2024;47(6):1074\u201383. https:\/\/doi.org\/10.2337\/dc24-0241.","journal-title":"Diabetes Care"},{"issue":"3","key":"3194_CR23","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2337\/diacare.24.3.539","volume":"24","author":"A Mari","year":"2001","unstructured":"Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care. 2001;24(3):539\u201348. https:\/\/doi.org\/10.2337\/diacare.24.3.539.","journal-title":"Diabetes Care"},{"issue":"9","key":"3194_CR24","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","volume":"22","author":"M Matsuda","year":"1999","unstructured":"Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22(9):1462\u201370. https:\/\/doi.org\/10.2337\/diacare.22.9.1462.","journal-title":"Diabetes Care"},{"issue":"5","key":"3194_CR25","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.2337\/db05-1200","volume":"55","author":"MA Abdul-Ghani","year":"2006","unstructured":"Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes. 2006;55(5):1430\u20135. https:\/\/doi.org\/10.2337\/db05-1200.","journal-title":"Diabetes"},{"key":"3194_CR26","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/709691","volume":"2014","author":"W Tang","year":"2014","unstructured":"Tang W, Fu Q, Zhang Q, et al. The association between serum uric acid and residual \u03b2 -cell function in type 2 diabetes. J Diabetes Res. 2014;2014:709691. https:\/\/doi.org\/10.1155\/2014\/709691.","journal-title":"J Diabetes Res"},{"issue":"8","key":"3194_CR27","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.2337\/diacare.28.8.1936","volume":"28","author":"B Ahr\u00e9n","year":"2005","unstructured":"Ahr\u00e9n B, Pacini G, Foley JE, Schweizer A. Improved meal-related beta-cell function and insulin sensitivity by the dipeptidyl peptidase-IV inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year. Diabetes Care. 2005;28(8):1936\u201340. https:\/\/doi.org\/10.2337\/diacare.28.8.1936.","journal-title":"Diabetes Care"},{"issue":"1","key":"3194_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2020.05.032","volume":"182","author":"B Shen","year":"2020","unstructured":"Shen B, Yi X, Sun Y, et al. Proteomic and metabolomic characterization of COVID-19 patient sera. Cell. 2020;182(1):59-72.e15. https:\/\/doi.org\/10.1016\/j.cell.2020.05.032.","journal-title":"Cell"},{"issue":"6","key":"3194_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s11306-023-02018-6","volume":"19","author":"S An","year":"2023","unstructured":"An S, Wang R, Lu M, et al. MetaPro: a web-based metabolomics application for LC-MS data batch inspection and library curation. Metabolomics. 2023;19(6):57. https:\/\/doi.org\/10.1007\/s11306-023-02018-6.","journal-title":"Metabolomics"},{"issue":"3","key":"3194_CR30","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11306-007-0082-2","volume":"3","author":"LW Sumner","year":"2007","unstructured":"Sumner LW, Amberg A, Barrett D, et al. Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics. 2007;3(3):211\u201321. https:\/\/doi.org\/10.1007\/s11306-007-0082-2.","journal-title":"Metabolomics"},{"issue":"9","key":"3194_CR31","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1021\/jasms.0c00224","volume":"31","author":"P Phapale","year":"2020","unstructured":"Phapale P, Rai V, Mohanty AK, Srivastava S. Untargeted metabolomics workshop report: quality control considerations from sample preparation to data analysis. J Am Soc Mass Spectrom. 2020;31(9):2006\u201310. https:\/\/doi.org\/10.1021\/jasms.0c00224.","journal-title":"J Am Soc Mass Spectrom"},{"issue":"6","key":"3194_CR32","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1002\/hep.21178","volume":"43","author":"RK Sterling","year":"2006","unstructured":"Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection. Hepatology. 2006;43(6):1317\u201325. https:\/\/doi.org\/10.1002\/hep.21178.","journal-title":"Hepatology"},{"issue":"12","key":"3194_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101853","volume":"5","author":"EY Tan","year":"2024","unstructured":"Tan EY, Muthiah MD, Sanyal AJ. Metabolomics at the cutting edge of risk prediction of MASLD. Cell Rep Med. 2024;5(12):101853. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101853.","journal-title":"Cell Rep Med"},{"issue":"1","key":"3194_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-021-01526-5","volume":"20","author":"YN Flores","year":"2021","unstructured":"Flores YN, Amoon AT, Su B, et al. Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico. Lipids Health Dis. 2021;20(1):136. https:\/\/doi.org\/10.1186\/s12944-021-01526-5.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3194_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02049-2","volume":"22","author":"D Denimal","year":"2023","unstructured":"Denimal D, B\u00e9land-Bonenfant S, Pais-de-Barros JP, et al. Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes. Cardiovasc Diabetol. 2023;22(1):310. https:\/\/doi.org\/10.1186\/s12933-023-02049-2.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"3194_CR36","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/hep.23229","volume":"50","author":"P Puri","year":"2009","unstructured":"Puri P, Wiest MM, Cheung O, et al. The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology. 2009;50(6):1827\u201338. https:\/\/doi.org\/10.1002\/hep.23229.","journal-title":"Hepatology"},{"key":"3194_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/nu11030705","author":"EH van den Berg","year":"2019","unstructured":"van den Berg EH, Flores-Guerrero JL, Gruppen EG, et al. Non-alcoholic fatty liver disease and risk of incident Type 2 diabetes: role of circulating branched-chain amino acids. Nutrients. 2019. https:\/\/doi.org\/10.3390\/nu11030705.","journal-title":"Nutrients"},{"issue":"1","key":"3194_CR38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/mco.0000000000000706","volume":"24","author":"D Tric\u00f2","year":"2021","unstructured":"Tric\u00f2 D, Biancalana E, Solini A. Protein and amino acids in nonalcoholic fatty liver disease. Curr Opin Clin Nutr Metab Care. 2021;24(1):96\u2013101. https:\/\/doi.org\/10.1097\/mco.0000000000000706.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"issue":"3","key":"3194_CR39","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20167422","volume":"13","author":"A Mardinoglu","year":"2017","unstructured":"Mardinoglu A, Bjornson E, Zhang C, et al. Personal model-assisted identification of NAD(+) and\u00a0glutathione metabolism as intervention target in NAFLD. Mol Syst Biol. 2017;13(3):916. https:\/\/doi.org\/10.15252\/msb.20167422.","journal-title":"Mol Syst Biol"},{"issue":"4","key":"3194_CR40","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3390\/livers2040020","volume":"2","author":"D Fern\u00e1ndez-Ramos","year":"2022","unstructured":"Fern\u00e1ndez-Ramos D, Lopitz-Otsoa F, Millet O, Alonso C, Lu SC, Mato JM. One carbon metabolism and S-Adenosylmethionine in non-alcoholic fatty liver disease pathogenesis and subtypes. Livers. 2022;2(4):243\u201357. https:\/\/doi.org\/10.3390\/livers2040020.","journal-title":"Livers"},{"issue":"10","key":"3194_CR41","doi-asserted-by":"publisher","first-page":"3856","DOI":"10.1210\/jc.2018-00999","volume":"103","author":"M Pietzner","year":"2018","unstructured":"Pietzner M, Budde K, Homuth G, et al. Hepatic steatosis is associated with adverse molecular signatures in subjects without diabetes. J Clin Endocrinol Metab. 2018;103(10):3856\u201368. https:\/\/doi.org\/10.1210\/jc.2018-00999.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"3194_CR42","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1111\/j.1872-034X.2010.00704.x","volume":"40","author":"Y Sumida","year":"2010","unstructured":"Sumida Y, Yonei Y, Kanemasa K, et al. Lower circulating levels of dehydroepiandrosterone, independent of insulin resistance, is an important determinant of severity of non-alcoholic steatohepatitis in Japanese patients. Hepatol Res. 2010;40(9):901\u201310. https:\/\/doi.org\/10.1111\/j.1872-034X.2010.00704.x.","journal-title":"Hepatol Res"},{"issue":"18","key":"3194_CR43","doi-asserted-by":"publisher","first-page":"3313","DOI":"10.1007\/s00018-018-2860-6","volume":"75","author":"DH Ipsen","year":"2018","unstructured":"Ipsen DH, Lykkesfeldt J, Tveden-Nyborg P. Molecular mechanisms of hepatic lipid accumulation in non-alcoholic fatty liver disease. Cell Mol Life Sci. 2018;75(18):3313\u201327. https:\/\/doi.org\/10.1007\/s00018-018-2860-6.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"3194_CR44","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/mco.0000000000000612","volume":"23","author":"F Mariotti","year":"2020","unstructured":"Mariotti F. Arginine supplementation and cardiometabolic risk. Curr Opin Clin Nutr Metab Care. 2020;23(1):29\u201334. https:\/\/doi.org\/10.1097\/mco.0000000000000612.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"3194_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.hnm.2025.200310","volume":"41","author":"HL Fateh","year":"2025","unstructured":"Fateh HL, Najafabadi MS, Moludi J, Ahmed DH, Rahman HS, Tawfeeq HM. The role of L-Arginine in improvement of lipid profile, liver enzymes, and blood pressure: a systematic review of randomized control trial studies. Human Nutrition Metabol. 2025;41:200310. https:\/\/doi.org\/10.1016\/j.hnm.2025.200310.","journal-title":"Human Nutrition Metabol"},{"issue":"4","key":"3194_CR46","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/hep.32427","volume":"76","author":"I Mart\u00ednez-Arranz","year":"2022","unstructured":"Mart\u00ednez-Arranz I, Bruzzone C, Noureddin M, et al. Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles. Hepatology. 2022;76(4):1121\u201334. https:\/\/doi.org\/10.1002\/hep.32427.","journal-title":"Hepatology"},{"issue":"1","key":"3194_CR47","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ajcnut.2024.10.012","volume":"121","author":"X Sun","year":"2025","unstructured":"Sun X, Li F, Yan H, et al. Intermittent compared with continuous calorie restriction for treatment of metabolic dysfunction-associated steatotic liver disease: a randomized clinical trial. Am J Clin Nutr. 2025;121(1):158\u201366. https:\/\/doi.org\/10.1016\/j.ajcnut.2024.10.012.","journal-title":"Am J Clin Nutr"},{"issue":"1","key":"3194_CR48","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/hep.29465","volume":"67","author":"M Gaggini","year":"2018","unstructured":"Gaggini M, Carli F, Rosso C, et al. Altered amino acid concentrations in NAFLD: impact of obesity and insulin resistance. Hepatology. 2018;67(1):145\u201358. https:\/\/doi.org\/10.1002\/hep.29465.","journal-title":"Hepatology"},{"issue":"11","key":"3194_CR49","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1038\/s42255-019-0134-8","volume":"1","author":"SA Summers","year":"2019","unstructured":"Summers SA, Chaurasia B, Holland WL. Metabolic messengers: ceramides. Nat Metab. 2019;1(11):1051\u20138. https:\/\/doi.org\/10.1038\/s42255-019-0134-8.","journal-title":"Nat Metab"},{"key":"3194_CR50","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.ceb.2020.01.006","volume":"63","author":"K Funai","year":"2020","unstructured":"Funai K, Summers SA, Rutter J. Reign in the membrane: how common lipids govern mitochondrial function. Curr Opin Cell Biol. 2020;63:162\u201373. https:\/\/doi.org\/10.1016\/j.ceb.2020.01.006.","journal-title":"Curr Opin Cell Biol"},{"issue":"10","key":"3194_CR51","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41569-021-00536-1","volume":"18","author":"RH Choi","year":"2021","unstructured":"Choi RH, Tatum SM, Symons JD, Summers SA, Holland WL. Ceramides and other sphingolipids as drivers of cardiovascular disease. Nat Rev Cardiol. 2021;18(10):701\u201311. https:\/\/doi.org\/10.1038\/s41569-021-00536-1.","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"3194_CR52","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/s2213-8587(24)00318-8","volume":"13","author":"N Stefan","year":"2025","unstructured":"Stefan N, Yki-J\u00e4rvinen H, Neuschwander-Tetri BA. Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment. Lancet Diab Endocrinol. 2025;13(2):134\u201348. https:\/\/doi.org\/10.1016\/s2213-8587(24)00318-8.","journal-title":"Lancet Diab Endocrinol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03194-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03194-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03194-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T23:24:02Z","timestamp":1781652242000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03194-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3194"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03194-0","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"10 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The trial protocol was approved by the Ruijin Hospital Ethical Review Committee (Ruijin-2018-174). All participants provided written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"179"}}